Move to topTop

Tokyo ― Terumo Corporation (TSE: 4543 Section 1) today announced that in the meeting of the board of directors held on March 27, 2014, it was decided to newly elect two persons as members of the board of directors as below. The new appointments will be confirmed at the annual general meeting of shareholders on June 24, 2014.

Newly elected members

Shinjiro Sato

(Present Position: Senior Executive Officer, President, Cardiac & Vascular Company)

David Perez

(Present Position: Senior Executive Officer, President & CEO, Terumo BCT, Inc., Chairman of the Board, Terumo Global Blood Management Business)

About Terumo

Terumo (TSE: 4543) is a global leader in medical technology and has been committed to “Contributing to Society through Healthcare” for 100 years. Based in Tokyo and operating globally, Terumo employs more than 30,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions. The company started as a Japanese thermometer manufacturer, and has been supporting healthcare ever since. Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice such as transfusion systems, diabetes care, and peritoneal dialysis treatments. Terumo will further strive to be of value to patients, medical professionals, and society at large.

Among the information that Terumo discloses, the forward-looking statements including financial projections are based upon our assumptions using information available to us at the time and are not intended to be guarantees of future events or performance. Accordingly, it should be noted that actual results may differ from those forecasts or projections due to various factors. Factors affecting to actual results include, but are not limited to, changes in economic conditions surrounding Terumo, fluctuations of foreign exchange rates, and state of competition.

 

Information about products (including products currently in development) included in this material is not intended to constitute an advertisement or medical advice.